Russell Investments Group Ltd. Purchases 25,000 Shares of Joint Corp (JYNT)

Russell Investments Group Ltd. lifted its position in shares of Joint Corp (NASDAQ:JYNT) by 28.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 112,900 shares of the company’s stock after purchasing an additional 25,000 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.86% of Joint worth $538,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in the company. Captrust Financial Advisors acquired a new stake in shares of Joint during the 2nd quarter worth approximately $791,000. Boston Partners grew its holdings in shares of Joint by 25.4% during the 3rd quarter. Boston Partners now owns 189,200 shares of the company’s stock worth $901,000 after purchasing an additional 38,300 shares in the last quarter. Finally, White Pine Capital LLC grew its holdings in shares of Joint by 44.2% during the 2nd quarter. White Pine Capital LLC now owns 55,500 shares of the company’s stock worth $211,000 after purchasing an additional 17,000 shares in the last quarter. 45.24% of the stock is currently owned by institutional investors.

Shares of Joint Corp (JYNT) opened at $4.99 on Thursday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market capitalization of $67.05, a price-to-earnings ratio of -7.23 and a beta of 1.53. Joint Corp has a one year low of $2.62 and a one year high of $6.00.

Joint (NASDAQ:JYNT) last announced its quarterly earnings results on Thursday, November 9th. The company reported ($0.03) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.06) by $0.03. The business had revenue of $6.55 million for the quarter, compared to analyst estimates of $6.28 million. Joint had a negative return on equity of 98.28% and a negative net margin of 36.74%. equities analysts forecast that Joint Corp will post -0.27 earnings per share for the current year.

JYNT has been the topic of several recent research reports. ValuEngine raised Joint from a “sell” rating to a “hold” rating in a report on Sunday. Zacks Investment Research lowered Joint from a “buy” rating to a “hold” rating in a research note on Wednesday, October 11th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $5.86.

COPYRIGHT VIOLATION NOTICE: This story was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at

Joint Profile

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Want to see what other hedge funds are holding JYNT? Visit to get the latest 13F filings and insider trades for Joint Corp (NASDAQ:JYNT).

Institutional Ownership by Quarter for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply